Join our Webinars
Find out about the latest breakthroughs in clinical diagnostics and get valuable insights from international healthcare experts. With the goal of improving patient management in critical care settings, we have created a series of webinars that look at the latest diagnostic innovations and how they influence the clinical practice today.
On demand Webinars:
Kidney Transplantation
Proenkephalin A 119–159 (penKid) as a promising new biomarker candidate for early detection of delayed graft function after kidney transplantation
Join Dr. Christian Nußhag for a webinar where he presents real-world data on the kidney function biomarker proenkephalin A 119-159 (penKid) for diagnosing Delayed Graft Function (DGF) in patients after kidney transplantation. According to these first findings, penKid seems to outperform traditional markers in identifying delayed graft function within just 24 hours post-transplantation.
These data, presented at Kidney Week 2023 of the American Society of Nephrology (ASN), offer hope for the development of new strategies to improve early post-transplant care. DGF often leads to prolonged hospital stays, compromised long-term graft function and reduced quality of life for patients. There is a need for more accurate and timely methods to identify DGF and its extent, which the biomarker proenkephalin A 119-159 (penKid) aims to address.
Speaker: Dr. Christian Nusshag | Oberarzt, Nierenzentrum Heidelberg
Participation Fee: Free
Kidney function
The implementation of a novel kidney function biomarker in clinical routine
Even though AKI is affecting 1 in 3 patients in the intensive care units, there is a significant unmet need generated by late and unspecific standard diagnostic tools. With the goal of obtaining a more prompt and precise detection of worsening and improvement of kidney function, the Clinic for Operative Intensive Care and Intermediate Care at University Hospital RWTH Aachen has implemented an innovative biomarker in the clinical routine.
Prof. Dr. Gernot Marx will discuss about the change in practice needed to implement the kidney function biomarker Proenkephalin A 119-159 (penKid) in the daily routine. He will also approach the clinical applications where penKid shows potential to improve patient management.
Speaker: Univ.-Prof. Dr. med. Gernot Marx | Head of the Department of Intensive Care Medicine and Intermediate Care at the University Hospital RWTH Aachen
Participation Fee: Free
Acute Heart Failure
Using bio-ADM and penKid for optimization of AHF management in daily clinical practice
Acute Heart Failure (AHF) is a leading cause of hospitalization in the elderly population and it is commonly associated with poor outcomes. Early identification of high-risk patients and more reliable parameters to monitor disease progression and its outcomes may allow more effective management and a better outcome for AHF patients.
In this webinar, Prof. Parissis presents different clinical phenotypes of AHF and the role of the kidney function biomarker penKid and the biomarker bio-ADM for endothelial function in selecting and guiding optimal therapeutic interventions. He discusses two clinical cases of AHF using these biomarkers for early risk stratification and evaluation of treatment activities.
Speaker: Prof. John Parissis MD, PhD, Attikon General Hospital, Head of University Clinic of Emergency Medicine, University of Athens, Greece
Participation Fee: Free
Glomerular Filtration Rate
Using Proenkephalin as a Novel Biomarker to Estimate GFR
The standard of care to determine kidney function has significant limitations, including late detection of changes in kidney function and the influence of non-renal factors on its results. The biomarker Proenkephalin provides a solution to assess changes in kidney function earlier compared to creatinine.
Prof. Peter Pickkers (Radboud University, Nijmegen) will present the research background alongside a new GFR formula that translates penKid concentrations into an estimated GFR for the routine clinical use initially in adults.
Speaker: Prof. Dr. Peter Pickkers, Radboud University, Nijmegen
Participation Fee: Free
Webinar Series: Use of Biomarkers in the Emergency Department
Sepsis
Sepsis in the Emergency Department: recognizing high-risk patients with the biomarker Bioactive Adrenomedullin
Recognizing the high risk sepsis patients at the Emergency Department (ED) poses a certain challenge, yet a timely therapeutic intervention is crucial for the patients’ survival. Find out how a novel biomarker of endothelial function bioactive adrenomedullin can support diagnostics and clinical decisions in the ED.
Speaker: Prof. Salvatore Di Somma, MD PhD; University La Sapienza Rome
Participation Fee: Free
Acute Kidney Injury
Overcoming the limitations of Acute Kidney Injury (AKI) diagnostics in the Emergency Department: the biomarker Proenkephalin for early recognition of AKI
Acute Kidney Injury is a serious complication of multiple severe conditions such as sepsis, yet is difficult to recognize with the current standard of care diagnostics in the patients presented at the ED. The novel functional kidney biomarker Proenkephalin A can bridge the gap in timely diagnostics of AKI in the ED.
Speaker: Prof. Salvatore Di Somma, MD PhD; University La Sapienza Rome
Participation Fee: Free
POC
Point-of-care Diagnostics in the Emergency Department: Better Patient Management
Near patient diagnostics can greatly improve the time to intervention and the outcomes for the severely sick patients presented at the ED. Learn about the possibilities of near the patient testing of well known and novel biomarkers on the point-of-care platform IB10.
Speaker: Prof. Salvatore Di Somma, MD PhD; University La Sapienza Rome
Participation Fee: Free
Disclaimer
The information presented on the webinar(s) is meant for healthcare professionals only. The information provided does not claim to be exhaustive and is not intended to serve as medical advice, substitute for a doctor’s appointment, or be used for diagnosing or treating a disease.